While this current price erosion is disappointing for AVXL price, the issue is mostly due to outside issues IMO.
Nothing has changed fundamentally. Technically price was building and working on stabilizing at a higher level.
So what are the issues. The sector has been in a down trend since November as seen by XBI. The general market is now close to and threatening full out correction mode as seen in $SPX, SPY, $INDU etc. Perfect climate for AVXL shorters and bears to maximize their positions and goals. Nothing wrong with AVXL IMO. Just too much external weight to continue price building in the short term.
What does history tell us? AVXL will weather this current storm and price will rise and then approvals commence sustainable growth that hasn't occurred in the past will emerge. Call it rose colored glasses or whatever the naysayers spew, IMO AVXL is in the best position in its existence.
Pay attention to your individual situation as there is no guarantee. Blind faith doesn't work. After all, it is a company in a difficult biotech market and too many wish AVXL to fail. Understand how to mitigate risk. Biotechs on average take minimum 10-15 years from preclinical trials. Some very successful ones even longer. Gotta be patient and able to enjoy the journey with many ups and downs.
Green Trades Everyone.
Bullish
Market Data 
Markets 
AI
